Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Hypoxia, Uterine Cervical Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Locally Advanced Cervical Cancer

Carcinoma, Lobular

Breast Neoplasms

Pancreatic Neoplasms

Carcinoma, Neuroendocrine

Patients With Advanced Solid Tumor

Stomach Neoplasms

Small Cell Lung Carcinoma

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Adrenocortical Carcinoma

Glioblastoma

Advanced Non-Small Cell Lung Cancer

Gastric Cancer Peritoneal Metastases

Breast Neoplasms

Brain Neoplasms

Glioblastoma

Solid Tumor, Unspecified, Adult

Neoplasm Metastasis, Thymoma

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Adenocarcinoma Of Esophagus

Extensive Small Cell Lung Cancer

Pancreatic Neoplasms

Sarcoma, Kaposi

Carcinoma, Transitional Cell

Pancreatic Adenocarcinoma Metastatic

Esophageal Neoplasms, Esophagitis, Radiation Injuries

Non-Resectable Pancreas Carcinoma

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms

Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer

Prostatic Neoplasms

Prostatic Neoplasms

Recurrence, Lymphoma, T-Cell, Cutaneous

Carcinoma, Non-Small-Cell Lung

DMMR Colorectal Cancer

Multiple Myeloma

Lung Neoplasms

Polycystic Ovary Syndrome

Burkitt Lymphoma

Biliary Tract Neoplasms

Pancreatic Neoplasms

Advanced Gastric Cancer

Bile Duct Neoplasms

Bile Duct Neoplasms

Clinical Trials

SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors

KeyPemls-004

Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer

POSTILV

A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer

ROSALINE

Clinical Trial of Eribulin in Combination with Anrotinib for HER-2 Negative Locally Advanced or Metastatic Breast Cancer

ASCEND

Lu-DOTA-TATE

A Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors

Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma

First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy

Ipilimumab and Nivolumab Followed by Adjuvant Nivolumab in Locally Advanced or Limited Metastatic Melanoma

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

CaboACC

TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

Safety and Efficacy of Systemic Chemotherapy Plus PD-1 Inhibitor in Combination With Bevacizumab in Gastric Cancer With Peritoneal Metastasis

CESM

NANORAD2

Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients

FAPI

RELEVENT

Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer

RICE

A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer

Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis

A Study of sEphB4-HSA in Kaposi Sarcoma

A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma

PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDAC

Deep-sea Fish Oil for Prevention of Acute Radiation-induced Esophagitis

Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced Pancreatic Cancer

Cangpo Liujun Prescription on Cancer-related Fatigue in Advanced Colorectal Cancer With Spleen Deficiency and Dampness Excess

KICKSTART

PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC

Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer

LUCIDA_2

To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer

Mogamulizumab Q4week Dosing in Participants With R/R CTCL

Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer

TAURUS

ACHIEVE

SPIOMET4HEALTH

CD19CD22 CAR-T Therapy in Patients With High-Risk B Acute Lymphoblastic Leukemia (B-ALL).

Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer

Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer

Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer

AZD6738 Plus Durvalumab in Biliary Tract Cancer

DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer